Solutech Pharmaceuticals

SoluTech is a specialty biotechnology company focused on the development of advanced drug delivery platforms to overcome challenges associated with poorly water-soluble drugs. The company's proprietary Solu-Gel technology utilizes a nanoparticle-based approach to improve the solubility, stability, and bioavailability of complex therapeutic molecules, including small molecules and peptides. Originally established as a spin-out from the University of Connecticut, SoluTech's expertise is centered on creating long-acting injectable formulations for chronic and infectious diseases. In 2020, the company was acquired by Frontier Biotechnologies to integrate its formulation technology into Frontier's pipeline of innovative treatments for HIV and COVID-19.